Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 91 AL 105

The role of microbiome-host interactions in the development of Alzheimer´s disease

Weber C, Dilthey A, Finzer P.

Front Cell Infect Microbiol. 2023 Jun 2;13:1151021. doi: 10.3389/fcimb.2023.1151021. eCollection 2023.

Effects of exercise interventions in Alzheimer's disease: A meta-analysis

Roy SK, Wang JJ, Xu YM.

Brain Behav. 2023 Jul;13(7):e3051. doi: 10.1002/brb3.3051. Epub 2023 Jun 18.

Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study

Nakamura Y, Omori T, Kim R, Nishiyama K, Kikuchi T, Ishikawa I, Aoki H.

J Alzheimers Dis. 2023;94(2):685-693. doi: 10.3233/JAD-230387.

Commentary: Application of automatic semi-quantification in clinical routine positron emission tomography brain studies is here to stay

Oliveira FPM, Costa DC.

Eur Radiol. 2023 Jul;33(7):4564-4566. doi: 10.1007/s00330-023-09637-6. Epub 2023 Apr 13.

Artificial intelligence-based diagnosis of Alzheimer's disease with brain MRI images

Yao Z, Wang H, Yan W, Wang Z, Zhang W, Wang Z, Zhang G.

Eur J Radiol. 2023 Aug;165:110934. doi: 10.1016/j.ejrad.2023.110934. Epub 2023 Jun 20.

Frontal variant Alzheimer's disease: A systematic narrative synthesis

Brown A, Salo SK, Savage G.

Cortex. 2023 Sep;166:121-153. doi: 10.1016/j.cortex.2023.05.007. Epub 2023 Jun 1.

Editorial: Implications of Emerging Uses of Genetic Testing for Alzheimer's Disease

Blasco D, Roberts JS.

J Prev Alzheimers Dis. 2023;10(3):359-361. doi: 10.14283/jpad.2023.46.

Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program

Walsh T, Duff L, Riviere ME, Tariot PN, Doak K, Smith M, Borowsky B, Lopez Lopez C, Arratia PC, Liu F, Scholten I, Gordon D, Arbuckle J, Graf A, Quinn M, Ricart J, Langbaum JB.

J Prev Alzheimers Dis. 2023;10(3):453-463. doi: 10.14283/jpad.2023.27.

Atypical forms of Alzheimer's disease: patients not to forget

Montembeault M, Migliaccio R.

Curr Opin Neurol. 2023 Aug 1;36(4):245-252. doi: 10.1097/WCO.0000000000001182. Epub 2023 Jun 22.

APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM(2.5) Polluted Cities

Calderón-Garcidueñas L, Hernández-Luna J, Aiello-Mora M, Brito-Aguilar R, Evelson PA, Villarreal-Ríos R, Torres-Jardón R, Ayala A, Mukherjee PS.

Biomolecules. 2023 May 31;13(6):927. doi: 10.3390/biom13060927.

[Modern possibilities of early diagnosis of Alzheimer's disease in patients with primary open-angle glaucoma]

Bogolepova AN, Makhnovich EV, Kovalenko EA, Osinovskaya NA, Beregov MM, Zhuravleva AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(6):121-128. doi: 10.17116/jnevro2023123061121.

New cases of dementia are rising in elderly populations in Wales, UK

Stevenson-Hoare J, Schalkamp AK, Sandor C, Hardy J, Escott-Price V.

J Neurol Sci. 2023 Aug 15;451:120715. doi: 10.1016/j.jns.2023.120715. Epub 2023 Jun 19.

Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease

Bhatnagar D, Ladhe S, Kumar D.

Mol Neurobiol. 2023 Oct;60(10):5954-5974. doi: 10.1007/s12035-023-03446-0. Epub 2023 Jun 29.

Medical Assistance in Dying in Neurology

Kious BM.

Neurol Clin. 2023 Aug;41(3):443-454. doi: 10.1016/j.ncl.2023.03.002. Epub 2023 Apr 20.

Passive Alzheimer's immunotherapy: A promising or uncertain option?

Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B.

Ageing Res Rev. 2023 Sep;90:101996. doi: 10.1016/j.arr.2023.101996. Epub 2023 Jul 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias